Pharmaceutical products containing tocilizumab

Summary

The tender concerns the supply of pharmaceutical products containing tocilizumab in a single lot. Tenders must be submitted electronically by 19 October 2026 at 11:00. Price is the only award criterion. The bidder must meet the annual turnover requirement of EUR 550,000, hold a registration in the pharmaceutical sector, and submit the required evidence and European Single Procurement Document. A tender guarantee is required in the amount of 5% of the contract’s initial value excluding VAT, rounded up to the next ten euros. The tender must remain valid for 365 days.